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RESEARCH ARTICLE
A SURVEY ON THE CONSUMPTION, KNOWLEDGE AND ATTITUDE 
OF PREGNANT WOMEN TOWARD THE EFFECTS OF FOLIC ACID ON 
PREGNANCY OUTCOME IN TABRIZ
Abstract
Objective
While the effects of folic acid are well established in prevention of Neural 
Tube Defects (NTDs), these diseases have a high prevalence in Iran. In order to 
encourage folic acid supplement use in pregnancy, it is important to promote 
the awareness of women of childbearing age regarding folic acid importance in 
preventing NTDs. The aim of the present study was to study the knowledge and 
attitude of pregnant women on the effect of folic acid on pregnancy outcome 
and its use during pregnancy. 
Materials and Methods
A questionnaire was completed by 400 women from postnatal and prenatal 
wards/clinics using random sampling. The questionnaire included questions 
regarding demographic information, folic acid consumption in pregnancy and 
the attitude and knowledge of the participants on folic acid supplementation 
and the source of information on folic acid supplementation.
The questions were aimed at subjects’ knowledge of folic acid effects on fetal 
growth and development and prevention of NTDs and not prevention of 
anemia. Data was analyzed by SPSS software (ver. 13.5). 
Results
About 89.9% used folic acid supplements at some point of the pregnancy and 
53.7% knew it was beneficial for the fetus. Approximately, 25% and 34.8% 
of those who used folic acid believed that it was most useful when taken 
preconception and during the first trimester, respectively. Only 15.4% knew it 
could prevent NTDs. The most common information sources for folic acid use 
were physicians. 
Conclusion
Awareness and use of folic acid were most prevalent among Iranian women, 
especially among educated ones. The results showed areas in which further 
work could be helpful to improve awareness regarding the benefits of folic acid.
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Introduction
Folic acid is necessary for DNA (1-3) and RNA synthesis (1, 3) and is critical role 
in prevention of congenital defects such as fetal NTDs (4-8). Since Hibbard and 
Smithells’ suggestion in 1965 for a link between inadequate maternal intake of 
folic acid and NTDs in their offspring (9), the efficacy of supplementary folic acid 
before and during the first trimester of pregnancy has been shown in preventing both 
occurrence and recurrence of NTDs (10, 11). 
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The prevalence of NTDs at birth was reported to be 
28.7 per 10,000 births in Iran in 1998–2003 (12). The 
reported prevalence of NTDs in Iran is significantly 
higher than Texas, Germany, and Quebec (13-15). A 
study has showed that the prevalence of NTDs in Iran 
has a significant relationship with maternal serum folate 
level (16). Since fortifying the grain supply with folic 
acid in Iran is not a compulsory program yet, and studies 
have shown that usual nutrition is not sufficient to cover 
the recommended daily intake of 400 μg of folic acid 
(17, 18), and we need to tackle this problem elsewhere: 
improvement of folate intake by vitamin supplementation 
in women of childbearing age. 
As seen before in previous studies (19), (20), in order 
to encourage folic acid supplement use in pregnancy to 
prevent NTDs, it is important to promote the awareness 
of women of child bearing age regarding the importance 
of folic acid in preventing NTDs and other congenital 
problems. In doing so, it is necessary to evaluate the level 
of knowledge in the at-risk population. Previous studies 
in various countries such as the Netherlands (21-23), 
India (24), USA (13, 25-32), Ireland (33), Spain (34), 
Israel (35, 36), Japan (1, 37, 38), China (39) and South 
Africa (40) have shown different levels of awareness 
regarding the effects folic acid in preventing NTDs , and 
the best usage period. 
There is limitted research on folic acid awareness during 
pregnancy in Iran.  Therefore, in the present study, we 
tried to obtain information regarding the knowledge 
of the pregnant women on the effects of folic acid 
supplementation on the fetus (specially its effects in 
preventing NTDs, a prevalent neurological defect in 
Iran) and the level of folic acid supplementation in 
Tabriz, northwest of Iran. 
Materials and Methods
Data was collected between August 2006 and May 
2007 in Tabriz, Iran, using random sampling. Women 
attending their last prenatal clinic visit or those who 
were in the antenatal ward after birth were recruited to 
the study.
According to our university regulations, non-
interventional studies do not require ethical committee 
approval but we presented our study to the directors of 
the midwifery services of the divisions of obstetrics and 
gynecology and obtained their permission. The subjects 
were free in answering the questionnaire or withdrawal 
from the study at any time. Written information was 
given to the participants. One of the researchers was 
present at the time of completion of the questionnaires. 
Written informed consent was obtained from the 
participants. Women who did not agree to participate, 
had complicated labor, delivered babies with congenital 
malformations, or were too exhausted or difficult to 
examine were excluded. We also tried our best to protect 
our participants rights and confidentiality. 
Four hundred women from two maternity hospitals, one 
private and one public, participated in the study. Two 
hospitals served a mixed population from urban, semi 
rural and rural areas and were located at two different 
sites in the city. 
An original questionnaire was prepared in Farsi. The 
questions were divided into the following sections: 
demographic information, folic acid consumption 
in pregnancy and the attitude and knowledge of the 
participants on folic acid supplementation and the source 
of information on folic acid supplementation. The 
questions were aimed at mothers› knowledge regarding 
fetal growth and development and prevention of NTDs. 
The effects of folic acid on possible maternal anemia 
were not included in the questions.
SPSS software (ver. 13.5) was used for analyzing data. 
Chi-square test was used for examining the significant 
level of data distribution between variables of each 
question and Student’s t-test, Pearson correlations and 
ANOVA was performed in order to examine the possible 
relationship between various factors. A significant level 
of P < 0.05 was adopted for all tests.
Results
Out of 427 women attending the two maternity hospitals, 
400 were recruited to the study and completed the 
questionnaire (93.7% participation rate). The participants 
aged 15 to 44 years old with a mean age of 26.5 ± 4.9 
and half of the subjects aged less than 26 years. The age 
distribution of the participants are seen in Table 1. Of 
them, 17.3% had university education and 36.8% had 
high school diploma. About 72.3% lived in the cities 
and 7.5% reported unsuccessful previous pregnancies. 
The number of pregnancies ranged between one and 
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five (2.6 ± 1.1). Only four mothers reported illness in 
their previous children. Information on number of the 
previous pregnancies and outcome of the current and 
previous pregnancies are seen in Table 2.
Out of the 359 participants who used folic acid 
supplements (Figure 1), 25.07% and 34.82% reported 
taking folic acid supplements preconceptionally (one 
month prior to the pregnancy) and during first trimester, 
respectively. About 54% of the participants knew that 
folic acid was useful for fetal health, 19.5% reported 
the preconceptional period as the most important time 
for folic acid effects on fetal growth and development 
and 33% reported the first trimester as important in 
this regard (Figure 2). Out of the 132 participants who 
reported the first trimester as important for fetal growth 
and development, 52 reported the preconceptional 
period as an important time as well. Only 15.4% knew 
that it could prevent NTDs. While 32.3% of participants 
reported having no information regarding folic acid 
effects on fetus, 13% thought that folic acid had no 
positive effect on fetal growth and development. No 
one was aware that folic acid could be harmful for fetal 
growth or development (Figure 3).
Out of the 359 participants who took folic acid 
preconceptionally or during their pregnancy, 72.8% 
reported their obstetricians/ gynecologists and 22.2% 
reported health centers as the recommender of folic 
acid use. Self-medication or recommendation by media 
or friends/family members accounted for 2.8%, 1.7% 
and 1.1 %, respectively. Pharmacists had no role in 
promoting folic acid use in our participants. 
Forty-one women who did not use folic acid during their 
pregnancy were aged 22 to 37 years (25.4 ± 4.6) with 
0 to 4 previous children (1.6 ± 1.1). The women who 
used folic acid in their pregnancy had a wider age range 
(15 to 40; 26.3 ± 4.9) with fewer children (0 to 3; 064 
±081) with a pregnancy frequency of 1 to 5 (1.8 ±09). 
More than half of the women in this group had high 
school diploma or university education and 73.5% lived 
in urban areas. About 7% of women reported having 
children with a physical illness but the type of problem 
was not inquired.  The main recommender of folic acid 
usage for this group was their doctors or health centers.
There was a significant relationship between the 
number of pregnancies and the participants’ attitude 
regarding the importance of folic acid supplements 
for fetal growth and its use either preconceptionally or 
during pregnancy. Area of residence and the level of 
the education of the participants had significant effects 
on the awareness of participants on the necessity of 
folic acid supplementation during pregnancy and on its 
consumption. Level of education also had a significant 
correlation with information regarding the important 
period of folic acid supplementation but not folate usage. 
Factors such as participants’ age or presence of illnesses 
in the mother did not have a significant effect on folic 
acid supplementation or participants’ attitude toward its 
necessity and benefits in pregnancy.
Discussion
 It is already known that folic acid supplementation prior 
to pregnancy and during the first trimester of pregnancy 
effectively prevents neural tube defects (9-11). Taking 
0.4 mg folic acid per day could prevent NTDs. However, 
its consumption level correlates with the level of 
awareness in the women of childbearing age. 
Compare to similar studies (1, 13, 21-40), a significant 
number of our participants knew that folic acid was useful 
for fetal health but a lesser percentage knew it could 
prevent NTDs. Although about half of our participants 
knew folic acid was useful for fetal growth, only about 
half of them reported taking folic acid preconceptionally 
and about one third reported folic acid consumption 
during the first 12 weeks of pregnancy meaning that 
in spite of a relatively good level of awareness among 
our participants, compliance was low, especially 
preconceptionally, A previous study in United Arab 
Emirates showed that 46.4% of the respondents had 
heard about folic acid and 45.5% of respondents took 
folic acid in the first trimester but only 8.7% knew that 
it prevented birth defects (41). In a Croatian study, about 
72% of the pregnant women were aware of the benefits of 
folic acid (42). It is expected that in planned pregnancies, 
folic acid consumption would be high but despite having 
75.53% of the pregnancies as planned, only 14.41% of 
all women took folic acid appropriately in the Croation 
study. In the former study, the level of awareness was 
lower than our study but the supplementation level was 
higher than our population while in the latter study, had 
similar level of awareness but a lower level of folic acid 
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supplementation was noted.
In Iran, there are government health centres in which 
midwives, nurses and general practitioners  cover 
different medical and health needs of the population. 
These health centres are distributed in every city and 
village. One of the services provided in these centres are 
necessary cares during pregnancy which cover a vast 
range of services including providing pregnant women 
with the necessary medications and supplementations 
such as folic acid and iron supplements. These services 
are provided free of charge (further information can be 
found at Eastern Mediterranean Regional Health System 
Observatory website). Folic acid is also available at a 
low price in pharmacies. These two sources of folic 
acid could be the reason for higher usage of folic acid in 
our participants compared to studies in other countries 
(19, 22, 33, 35, 41, 43), but there is still area for further 
educational work. 
In previous studies, age (35), race (35, 44, 45), education 
(41, 44, 45), planned pregnancy (44, 45), presence of 
NTDs in previous child(ren) (44), receiving advice on 
folic acid use (prior to pregnancy and postpartum) (44) 
and religiosity (35) were the factors with significant 
effects on the attitude of the participants and folic 
acid supplementation during pregnancy. An increased 
number of pregnancies and history of consultation with 
physicians, health providers and midwives could also be 
other effective factors in promoting women’s knowledge 
regarding pregnancy and fetal growth and therefore 
folic acid intake. We were able to show that the gravid 
number was significantly related to the participants’ 
attitude toward the importance of folic acid supplement 
on fetal growth and its use either preconceptionally or 
during pregnancy. In a previous study in Iran, Kashani 
and colleagues included only gravid 1 women into 
their study (46) and reported lower folic acid usage and 
lower levels of awareness. We were also able to show 
that the residential area and level of education had 
significant effects on the awareness of the participants 
about the necessity of folic acid supplementation during 
pregnancy and also with folic acid use. The level of 
folic acid supplementation was low in participants 
who lived in rural areas. There was also a significant 
correlation between information regarding the important 
period of folic acid supplementation (but not folate 
usage) and the level of education. The participants 
with university education correctly identified the time 
as preconceptionally and the first trimester as the best 
time for folic acid supplementation. Other factors such 
as age or presence of illnesses in the mother did not 
have a significant effect on folic acid supplementation 
or participants’ attitude on its necessity and benefits in 
pregnancy, similar to Ringel’s study (35). 
Unlike Croatian and Thai studies (42,47), in which the 
information for folic acid promotion mostly came from 
the media and then the physicians, the most influential 
factors of folic acid use were physicians and health care 
centers in the present study. In Iran, many women visit 
their obstetrician/gynecologist regularly and receive 
advice on medication use. This could be another reason 
for higher folic acid consumption in Iran. In health care 
centers (health houses), women receive care prior, during 
and after pregnancy by specially trained staff including 
midwives, nurse-midwives or general practitioners. 
Our study showed that media only played a very weak 
role in educating our participants but since media 
could address a wider range of people, it is necessary 
to emphasize more on educational programs on radio 
and television and heath related articles on journals 
and magazines. These resources could enhance 
awareness. We also noted that the pharmacists’ role 
was not substantial. One of the most important duties 
of pharmacists is to provide information to the public 
including pregnant women. Further work is needed to 
heighten this important role for pharmacist and to boost 
the awareness of the public regarding this duty. 
Although taking a folic acid tablet per day (0.4 mg) is 
a simple measure to prevent severe birth defects, it is 
under-promoted in the media, under-recommended 
by health care providers and underused by women of 
childbearing age. Therefore, further effort is required 
and it is necessary to start early on, probably during 
premarital counseling or even during high school 
education. Further counseling programs could increase 
the level of awareness among this group and increase the 
consumption of folic acid in the correct time to prevent 
NTDs, a prevalent but greatly preventable problem in 
Iran.
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Figure 1. Administration of folic acid by subjects 
Figure 2. The attitude of the participants toward the best time for folic acid supplementation with respect to 
pregnancy outcome
Figure 3. The attitude of the participants toward the necessity of folic acid supplementation during 
pregnancy
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Table 1: Age distribution of the study population














Table 2: History of previous pregnancies and outcome 
of the current and previous pregnancies in the study 
population
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